EVOKE PHARMA INC (EVOK)

US30049G2030 - Common Stock

0.4855  +0.03 (+6.07%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
5.18M2.51M1.62M20.00K0.00
Cost Of Goods
201.88K370.00K330.00K90.00KN/A
Gross Profit
4.98M2.14M1.29M-60.00KN/A
Operating Expenses
12.41M9.92M9.44M12.98M7.15M
Research and Development
181.91K300.00K590.00K6.55M3.42M
Selling, General, and Administrative Expenses
12.23M9.62M8.85M6.43M3.74M
Operating Income
-7.43M-7.79M-8.15M-13.05M-7.15M
Interest Income/Expense
-361.40K-440.00K-490.00K-110.00K30.00K
Other Income/Expense
N/A0.00110.00KN/A0.00
Income Before Taxes
-7.79M-8.22M-8.54M-13.15M-7.13M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-7.79M-8.22M-8.54M-13.15M-7.13M
 
Per Share Data
EPS Diluted Total Ops
-2.33-2.62-3.18-6.19-3.84
Non GAAP EPS
-2.33-2.68-3.24-6.24-3.96
 
Statistics
Gross Profit Margin
96.10%85.26%79.63%-300.00%N/A
Profit Margin
-150.41%-327.49%-527.16%-65750.00%N/A
Operating Profit Margin
-143.44%-310.36%-503.09%-65250.00%N/A

All data in USD

Charts